![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Rennekamp Andrew J Lieberman Paul M
Publisher: Future Medicine
ISSN: 1746-0794
Source: Future Virology, Vol.5, Iss.1, 2010-01, pp. : 65-83
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lytic replication of Epstein–Barr virus
Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Epstein–Barr virus: novel patented therapeutics
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. :